FDA — authorised 18 January 1966
- Marketing authorisation holder: ASPEN GLOBAL INC
- Status: approved
🇺🇸 Thioguanine in United States
FDA authorised Thioguanine on 18 January 1966
Marketing authorisations
FDA — authorised 18 January 1966
- Application: NDA012429
- Marketing authorisation holder: WAYLIS THERAP
- Local brand name: THIOGUANINE
- Indication: TABLET — ORAL
- Status: approved
Thioguanine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Thioguanine approved in United States?
Yes. FDA authorised it on 18 January 1966; FDA authorised it on 18 January 1966.
Who is the marketing authorisation holder for Thioguanine in United States?
ASPEN GLOBAL INC holds the US marketing authorisation.